KYTX
Kyverna Therapeutics, Inc.
Price Chart
No historical data available
Latest Quote
$8.47
+0.11 (+1.25%)
Current Price
| Previous Close | $8.37 |
| Open | $8.33 |
| Day High | $8.52 |
| Day Low | $8.16 |
| Volume | 473,720 |
Stock Information
| Shares Outstanding | 61.84M |
| Total Debt | $33.00M |
| Cash Equivalents | $199.43M |
| Net Income | $-152.64M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $524.12M |
| EPS (TTM) | $-2.96 |
| Exchange | NMS |
Recent Price History
No history data available. Data will be fetched automatically.
About Kyverna Therapeutics, Inc.
Kyverna Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on developing cell therapies for patients with autoimmune diseases. Its lead product candidate is KYV-101, an autologous CD19 CAR T-cell product candidate for the treatment of stiff person syndrome, myasthenia gravis, and autoimmune diseases. The company is also developing KYV-102, an autologous CD19 CAR T-cell product candidate with whole blood rapid manufacturing; and KYV-201, an allogeneic CD19 CAR T-cell product candidate. It has a license and collaboration agreement with Intellia Therapeutics, Inc. to research and develop an allogeneic CD19-directed CAR cell therapy product. The company was formerly known as BAIT Therapeutics, Inc. and changed its name to Kyverna Therapeutics, Inc. in October 2019. Kyverna Therapeutics, Inc. was incorporated in 2018 and is headquartered in Emeryville, California.
đ° Latest News
No news articles available at the moment. Check back later for updates on KYTX.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $7,025,000 |
| Operating Revenue | $0 | $0 | $0 | $7,025,000 |
| Expenses | ||||
| Interest Expense | $489,000 | $142,000 | $187,000 | $65,000 |
| Total Expenses | $169,827,000 | $142,604,000 | $62,406,000 | $36,409,000 |
| Other Income Expense | $-85,000 | $-90,000 | $-55,000 | $-9,000 |
| Other Non Operating Income Expenses | $-85,000 | $-90,000 | $-55,000 | $-9,000 |
| Net Non Operating Interest Income Expense | $8,605,000 | $15,217,000 | $2,095,000 | $500,000 |
| Interest Expense Non Operating | $489,000 | $142,000 | $187,000 | $65,000 |
| Operating Expense | $169,827,000 | $142,604,000 | $62,406,000 | $36,409,000 |
| General And Administrative Expense | $36,107,000 | $30,131,000 | $12,483,000 | $8,007,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-161,307,000 | $-127,477,000 | $-60,366,000 | $-28,893,000 |
| Net Interest Income | $8,605,000 | $15,217,000 | $2,095,000 | $500,000 |
| Interest Income | $9,094,000 | $15,359,000 | $2,282,000 | $565,000 |
| Normalized Income | $-161,307,000 | $-127,477,000 | $-60,366,000 | $-28,893,000 |
| Net Income From Continuing And Discontinued Operation | $-161,307,000 | $-127,477,000 | $-60,366,000 | $-28,893,000 |
| Total Operating Income As Reported | $-169,827,000 | $-142,604,000 | $-62,406,000 | $-29,384,000 |
| Net Income Common Stockholders | $-161,307,000 | $-127,477,000 | $-60,366,000 | $-28,893,000 |
| Net Income | $-161,307,000 | $-127,477,000 | $-60,366,000 | $-28,893,000 |
| Net Income Including Noncontrolling Interests | $-161,307,000 | $-127,477,000 | $-60,366,000 | $-28,893,000 |
| Net Income Continuous Operations | $-161,307,000 | $-127,477,000 | $-60,366,000 | $-28,893,000 |
| Pretax Income | $-161,307,000 | $-127,477,000 | $-60,366,000 | $-28,893,000 |
| Interest Income Non Operating | $9,094,000 | $15,359,000 | $2,282,000 | $565,000 |
| Operating Income | $-169,827,000 | $-142,604,000 | $-62,406,000 | $-29,384,000 |
| Per Share | ||||
| Diluted EPS | $-3.64 | $-3.33 | $-1.48 | $-1.12 |
| Basic EPS | $-3.64 | $-3.33 | $-1.48 | $-1.12 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-159,019,000 | $-125,202,000 | $-58,472,000 | $-27,777,000 |
| Reconciled Depreciation | $1,799,000 | $2,133,000 | $1,707,000 | $1,051,000 |
| EBITDA (Bullshit earnings) | $-159,019,000 | $-125,202,000 | $-58,472,000 | $-27,777,000 |
| EBIT | $-160,818,000 | $-127,335,000 | $-60,179,000 | $-28,828,000 |
| Diluted Average Shares | $44,259,999 | $38,334,571 | $40,822,525 | $25,803,889 |
| Basic Average Shares | $44,259,999 | $38,334,571 | $40,822,525 | $25,803,889 |
| Diluted NI Availto Com Stockholders | $-161,307,000 | $-127,477,000 | $-60,366,000 | $-28,893,000 |
| Research And Development | $133,720,000 | $112,473,000 | $49,923,000 | $28,402,000 |
| Selling General And Administration | $36,107,000 | $30,131,000 | $12,483,000 | $8,007,000 |
| Other Gand A | $36,107,000 | $30,131,000 | $12,483,000 | $8,007,000 |
Fetched: 2026-08-29
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $232,276,000 | $266,587,000 | $-131,397,000 | $-73,997,000 |
| Total Assets | $293,826,000 | $304,645,000 | $75,195,000 | $66,924,000 |
| Total Non Current Assets | $10,873,000 | $14,044,000 | $14,531,000 | $13,673,000 |
| Other Non Current Assets | $5,454,000 | $3,388,000 | $3,921,000 | $1,232,000 |
| Current Assets | $282,953,000 | $290,601,000 | $60,664,000 | $53,251,000 |
| Other Current Assets | $3,700,000 | $4,622,000 | $3,121,000 | $1,929,000 |
| Cash Cash Equivalents And Short Term Investments | $279,253,000 | $285,979,000 | $57,543,000 | $51,322,000 |
| Cash And Cash Equivalents | $124,093,000 | $96,621,000 | $34,647,000 | $37,735,000 |
| Debt | ||||
| Total Debt | $29,032,000 | $8,242,000 | $9,079,000 | $10,564,000 |
| Long Term Debt And Capital Lease Obligation | $25,063,000 | $4,302,000 | $6,159,000 | $8,287,000 |
| Long Term Debt | $24,743,000 | - | - | - |
| Current Debt And Capital Lease Obligation | $3,969,000 | $3,940,000 | $2,920,000 | $2,277,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $61,550,000 | $38,058,000 | $206,592,000 | $140,921,000 |
| Total Non Current Liabilities Net Minority Interest | $25,063,000 | $4,302,000 | $186,733,000 | $128,967,000 |
| Current Liabilities | $36,487,000 | $33,756,000 | $19,859,000 | $11,954,000 |
| Payables And Accrued Expenses | $22,528,000 | $24,933,000 | $14,127,000 | $7,701,000 |
| Payables | $5,306,000 | $4,624,000 | $4,358,000 | $1,451,000 |
| Accounts Payable | $5,306,000 | $4,624,000 | $4,358,000 | $1,451,000 |
| Other Current Liabilities | - | - | $3,519,000 | $565,000 |
| Other Non Current Liabilities | - | - | - | $6,000 |
| Non Current Deferred Liabilities | - | - | - | $0 |
| Current Deferred Liabilities | - | - | - | $0 |
| Equity | ||||
| Common Stock Equity | $232,276,000 | $266,587,000 | $-131,397,000 | $-73,997,000 |
| Total Equity Gross Minority Interest | $232,276,000 | $266,587,000 | $-131,397,000 | $-73,997,000 |
| Stockholders Equity | $232,276,000 | $266,587,000 | $-131,397,000 | $-73,997,000 |
| Gains Losses Not Affecting Retained Earnings | $97,000 | $105,000 | $4,000 | $-26,000 |
| Other Equity Adjustments | $97,000 | $105,000 | $4,000 | $-26,000 |
| Retained Earnings | $-424,827,000 | $-263,520,000 | $-136,043,000 | $-75,677,000 |
| Preferred Securities Outside Stock Equity | - | $0 | $180,574,000 | $120,674,000 |
| Other | ||||
| Ordinary Shares Number | $60,389,893 | $43,214,918 | $43,115,244 | $40,822,525 |
| Share Issued | $60,389,893 | $43,214,918 | $43,115,244 | $40,822,525 |
| Tangible Book Value | $232,276,000 | $266,587,000 | $-131,397,000 | $-73,997,000 |
| Invested Capital | $257,019,000 | $266,587,000 | $-131,397,000 | $-73,997,000 |
| Working Capital | $246,466,000 | $256,845,000 | $40,805,000 | $41,297,000 |
| Capital Lease Obligations | $4,289,000 | $8,242,000 | $9,079,000 | $10,564,000 |
| Total Capitalization | $257,019,000 | $266,587,000 | $-131,397,000 | $-73,997,000 |
| Additional Paid In Capital | $657,005,000 | $530,002,000 | $4,642,000 | $1,706,000 |
| Capital Stock | $1,000 | $0 | $0 | $0 |
| Common Stock | $1,000 | $0 | $0 | $0 |
| Preferred Stock | $0 | $0 | $0 | - |
| Long Term Capital Lease Obligation | $320,000 | $4,302,000 | $6,159,000 | $8,287,000 |
| Current Capital Lease Obligation | $3,969,000 | $3,940,000 | $2,920,000 | $2,277,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $9,990,000 | $4,883,000 | $2,812,000 | $1,411,000 |
| Current Accrued Expenses | $17,222,000 | $20,309,000 | $9,769,000 | $6,250,000 |
| Net PPE | $5,419,000 | $10,656,000 | $10,610,000 | $12,441,000 |
| Accumulated Depreciation | $-3,750,000 | $-3,672,000 | $-2,488,000 | $-1,618,000 |
| Gross PPE | $9,169,000 | $14,328,000 | $13,098,000 | $14,059,000 |
| Leases | $936,000 | $821,000 | $645,000 | $456,000 |
| Other Properties | $6,937,000 | $11,439,000 | $11,693,000 | $12,931,000 |
| Machinery Furniture Equipment | $1,296,000 | $2,068,000 | $760,000 | $672,000 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $155,160,000 | $189,358,000 | $22,896,000 | $13,587,000 |
| Non Current Accrued Expenses | - | - | - | $0 |
| Non Current Deferred Revenue | - | - | - | $0 |
| Current Deferred Revenue | - | - | - | $0 |
Fetched: 2026-08-29
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-154,845,000 | $-116,455,000 | $-53,031,000 | $-36,881,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-153,712,000 | $-114,250,000 | $-52,410,000 | $-36,113,000 |
| Cash Flow From Continuing Operating Activities | $-153,712,000 | $-114,250,000 | $-52,410,000 | $-36,113,000 |
| Operating Gains Losses | $60,000 | - | - | - |
| Investing Activities | ||||
| Capital Expenditure | $-1,133,000 | $-2,205,000 | $-621,000 | $-768,000 |
| Investing Cash Flow | $40,015,000 | $-160,902,000 | $-8,785,000 | $-14,097,000 |
| Cash Flow From Continuing Investing Activities | $40,015,000 | $-160,902,000 | $-8,785,000 | $-14,097,000 |
| Capital Expenditure Reported | $-1,128,000 | $0 | - | - |
| Financing Activities | ||||
| Issuance Of Capital Stock | $140,608,000 | $341,171,000 | $59,900,000 | $11,954,000 |
| Financing Cash Flow | $141,168,000 | $337,113,000 | $58,118,000 | $11,880,000 |
| Cash Flow From Continuing Financing Activities | $141,168,000 | $337,113,000 | $58,118,000 | $11,880,000 |
| Net Other Financing Charges | $-619,000 | $-3,361,000 | $-1,646,000 | - |
| Net Preferred Stock Issuance | $24,700,000 | $0 | $59,900,000 | $11,954,000 |
| Preferred Stock Issuance | $24,700,000 | $0 | $59,900,000 | $11,954,000 |
| Net Common Stock Issuance | $115,908,000 | $341,171,000 | $0 | - |
| Common Stock Issuance | $115,908,000 | $341,171,000 | $0 | - |
| Other | ||||
| Repayment Of Debt | $-808,000 | $-956,000 | $-781,000 | $-249,000 |
| Interest Paid Supplemental Data | $415,000 | $142,000 | $187,000 | $65,000 |
| End Cash Position | $124,644,000 | $97,173,000 | $35,212,000 | $38,289,000 |
| Beginning Cash Position | $97,173,000 | $35,212,000 | $38,289,000 | $76,619,000 |
| Changes In Cash | $27,471,000 | $61,961,000 | $-3,077,000 | $-38,330,000 |
| Proceeds From Stock Option Exercised | $1,987,000 | $259,000 | $645,000 | $175,000 |
| Net Issuance Payments Of Debt | $-808,000 | $-956,000 | $-781,000 | $-249,000 |
| Net Long Term Debt Issuance | $-808,000 | $-956,000 | $-781,000 | $-249,000 |
| Long Term Debt Payments | $-808,000 | $-956,000 | $-781,000 | $-249,000 |
| Net Investment Purchase And Sale | $41,078,000 | $-158,697,000 | $-8,164,000 | $-13,329,000 |
| Sale Of Investment | $405,701,000 | $331,300,000 | $46,683,000 | $43,166,000 |
| Purchase Of Investment | $-364,623,000 | $-489,997,000 | $-54,847,000 | $-56,495,000 |
| Net PPE Purchase And Sale | $65,000 | $-2,205,000 | $-621,000 | $-768,000 |
| Sale Of PPE | $70,000 | $0 | - | - |
| Purchase Of PPE | $-5,000 | $-2,205,000 | $-621,000 | $-768,000 |
| Change In Working Capital | $-1,076,000 | $7,857,000 | $3,424,000 | $-10,327,000 |
| Change In Other Current Liabilities | $-3,339,000 | $-2,399,000 | $-1,679,000 | $-1,078,000 |
| Change In Other Current Assets | $-980,000 | $-1,955,000 | $-1,849,000 | $-637,000 |
| Change In Payables And Accrued Expense | $2,350,000 | $13,712,000 | $8,144,000 | $-678,000 |
| Change In Accrued Expense | $1,807,000 | $12,976,000 | $4,061,000 | $-1,355,000 |
| Change In Payable | $543,000 | $736,000 | $4,083,000 | $677,000 |
| Change In Account Payable | $543,000 | $736,000 | $4,083,000 | $677,000 |
| Change In Prepaid Assets | $893,000 | $-1,501,000 | $-1,192,000 | $-909,000 |
| Other Non Cash Items | $2,972,000 | $2,544,000 | $1,720,000 | $1,411,000 |
| Stock Based Compensation | $10,080,000 | $8,357,000 | $2,220,000 | $929,000 |
| Asset Impairment Charge | $648,000 | $0 | - | - |
| Amortization Of Securities | $-6,888,000 | $-7,664,000 | $-1,115,000 | $-284,000 |
| Depreciation Amortization Depletion | $1,799,000 | $2,133,000 | $1,707,000 | $1,051,000 |
| Depreciation And Amortization | $1,799,000 | $2,133,000 | $1,707,000 | $1,051,000 |
| Gain Loss On Sale Of PPE | $60,000 | $0 | - | $0 |
| Net Income From Continuing Operations | $-161,307,000 | $-127,477,000 | $-60,366,000 | $-28,893,000 |
| Change In Other Working Capital | - | - | - | $-7,025,000 |
Fetched: 2026-08-29